Quarterly ResultMay 11, 2026, 05:08 PM
Agenus Swings to Q1 Net Income $39.2M; Zydus Asset Sale Boosts Cash
AI Summary
Agenus reported a significant swing to net income of $39.172 million, or $1.03 basic EPS, for the first quarter of 2026, compared to a net loss in the prior year. This improvement was largely driven by a $40.379 million gain from the Zydus asset sale and reduced operating expenses. The company's cash and cash equivalents increased substantially to $35.0 million, bolstering its liquidity position. However, management noted substantial doubt about its ability to continue as a going concern for at least one year, despite expecting existing cash and anticipated revenues to support liquidity into 2027.
Key Highlights
- Net income attributable to common stockholders was $39.172 million in Q1 2026, compared to a net loss of $(25.320) million in Q1 2025.
- Basic EPS swung to $1.03 in Q1 2026 from $(1.03) in Q1 2025.
- Total revenues increased 40.2% to $33.736 million in Q1 2026 from $24.066 million in Q1 2025.
- A gain of $40.379 million was recognized on the Zydus asset sale in Q1 2026.
- Cash and cash equivalents rose to $35.0 million as of March 31, 2026, from $3.0 million at December 31, 2025.
- Research and development expenses decreased to $11.822 million in Q1 2026 from $21.522 million in Q1 2025.
- General and administrative expenses decreased to $6.860 million in Q1 2026 from $15.718 million in Q1 2025.
- Principal amount of outstanding debt decreased to $30.5 million as of March 31, 2026, from $45.5 million at December 31, 2025.
- Substantial doubt exists about the company's ability to continue as a going concern for at least one year.
Price Impact
More from AGEN